Description

Key Characteristics

• 10mg BPC-157 + 10mg TB-500 per vial (20mg combined)
• Complementary mechanisms: BPC-157’s localized tissue support paired with TB-500’s broader remodeling and cell-migration activity
• Single-vial format simplifies co-administration protocols in research settings

Primary Research Focus Areas

• Tendon, ligament, and muscle recovery models
• Chronic and acute injury research
• Systemic inflammation and mobility studies

Preparation & Storage

• Reconstitute with bacteriostatic water; dissolve gently without shaking
• Store unreconstituted powder at -20°C
• Refrigerate reconstituted solution at 2–8°C; use within 30 days

Research Chemical: NOT FOR HUMAN CONSUMPTION. For laboratory research and in vitro use only. Not FDA approved.